InspireMD, Inc. (NSPR)

Price$0.99

Value ScoreB

Growth ScoreB

Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-61.77%

Price vs S&P 500 (4W)-24.91%

VGM Score49.68

Market Capitalization$43.12M

All Metrics

Book Value / Share (Quarterly)$0.93

P/TBV (Annual)3.61x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)20.20%

Cash Flow / Share (Quarterly)$-0.86

Price vs S&P 500 (YTD)-59.21%

Gross Margin (TTM)28.06%

Net Profit Margin (TTM)-472.98%

EPS (TTM)$-0.74

10-Day Avg Trading Volume0.20M

EPS Excl Extra (TTM)$-0.74

Revenue Growth (5Y)29.24%

EPS (Annual)$-0.76

ROI (Annual)-88.38%

Gross Margin (Annual)29.50%

Net Profit Margin (5Y Avg)-402.03%

Cash / Share (Quarterly)$0.89

Revenue Growth QoQ (YoY)61.57%

ROA (Last FY)-70.29%

Revenue Growth TTM (YoY)6.29%

EBITD / Share (TTM)$-0.71

ROE (5Y Avg)-75.66%

Operating Margin (TTM)-480.57%

Cash Flow / Share (Annual)$-0.84

P/B Ratio0.99x

P/B Ratio (Quarterly)1.75x

Net Income / Employee (Annual)$-384,100

EV / Revenue (TTM)2.93x

Net Interest Coverage (TTM)-69.08x

ROA (TTM)-86.35%

EPS Incl Extra (Annual)$-0.76

Current Ratio (Annual)5.74x

Quick Ratio (Quarterly)4.70x

3-Month Avg Trading Volume0.20M

52-Week Price Return-64.04%

Revenue / Employee (TTM)$85,400

Tangible BV / Share (Quarterly)$2.02

P/S Ratio (Annual)4.80x

Asset Turnover (Annual)0.13x

52-Week High$2.93

Operating Margin (5Y Avg)-412.06%

EPS Excl Extra (Annual)$-0.76

CapEx CAGR (5Y)79.18%

Tangible BV CAGR (5Y)42.11%

26-Week Price Return-45.84%

Quick Ratio (Annual)5.30x

13-Week Price Return-49.69%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)5.15x

Enterprise Value$31.76M

Revenue / Share Growth (5Y)-38.97%

Asset Turnover (TTM)0.18x

Book Value / Share Growth (5Y)-19.32%

Revenue / Employee (Annual)$70,700

Inventory Turnover (Annual)2.12x

Pretax Margin (Annual)-542.63%

Cash / Share (Annual)$1.25

3-Month Return Std Dev57.68%

Gross Margin (5Y Avg)23.69%

Net Income / Employee (TTM)$-404,000

ROE (Last FY)-88.38%

Net Interest Coverage (Annual)-11.49x

EPS Basic Excl Extra (Annual)$-0.76

Receivables Turnover (TTM)5.48x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.74

Receivables Turnover (Annual)4.80x

ROI (TTM)-112.04%

P/S Ratio (TTM)3.98x

Pretax Margin (5Y Avg)-401.17%

Revenue / Share (Annual)$0.14

Tangible BV / Share (Annual)$2.09

Price vs S&P 500 (52W)-92.24%

Year-to-Date Return-48.28%

5-Day Price Return-7.93%

EPS Normalized (Annual)$-0.76

ROA (5Y Avg)-58.61%

Net Profit Margin (Annual)-543.33%

Month-to-Date Return-21.97%

Cash Flow / Share (TTM)$-0.79

EBITD / Share (Annual)$-0.76

Operating Margin (Annual)-552.56%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-75.66%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.74

P/TBV (Quarterly)1.45x

P/B Ratio (Annual)1.37x

Inventory Turnover (TTM)2.66x

Pretax Margin (TTM)-472.40%

Book Value / Share (Annual)$1.27

Price vs S&P 500 (13W)-59.43%

Beta0.77x

Revenue / Share (TTM)$0.13

ROE (TTM)-112.04%

52-Week Low$0.86

vGradeB

gGradeB

mGradeF

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.16est. -0.18

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.13

4.11

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
NSPRInspireMD, Inc.	B	B	F	$0.99
SYKStryker Corporation	C	C	D	$299.46
MMM3M Company	C	F	C	$150.93
BSXBoston Scientific Corp.	C	B	F	$47.98
MDLNMedline Inc. Class A common stock	C	D	D	$35.75
BDXBecton, Dickinson and Co.	B	C	C	$145.33
DXCMDexCom, Inc.	C	B	C	$74.87
RMDResMed Inc.	B	B	D	$186.44
WSTWest Pharmaceutical Services, Inc.	D	C	B	$316.30
SOLVSolventum Corporation	C	D	C	$75.84
PENPenumbra, Inc.	F	C	C	$318.95

About

InspireMD is a U.S.-based medical device company specializing in proprietary MicroNet stent platform technology for treating complex vascular and coronary disease. Its primary revenue driver is the CGuard carotid Embolic Prevention System, which combines the company's proprietary MicroNet technology with a self-expandable stent for carotid artery applications. The company also offers the MGuard Prime Embolic Protection System and maintains operations across Europe and Russia.